Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Antibody treatment protects monkeys from Hendra virus disease

20.10.2011
NIH-supported group exploring whether protection extends to Nipah virus disease

A human antibody given to monkeys infected with the deadly Hendra virus completely protected them from disease, according to a study published by National Institutes of Health (NIH) scientists and their collaborators.


This is the Hendra virus.
Credit: Courtesy Dr. Alex Hyatt, AAHL

Hendra and the closely related Nipah virus, both rare viruses that are part of the NIH biodefense research program, target the lungs and brain and have human case fatality rates of 60 percent and more than 75 percent, respectively. These diseases in monkeys mirror what happens in humans, and the study results are cause for hope that the antibody, named m102.4, ultimately may be developed into a possible treatment for people who become infected with these viruses.

In May 2010, shortly after the NIH study in monkeys successfully concluded, Australian health officials requested m102.4 for emergency use in a woman and her 12-year-old daughter. They had been exposed to Hendra virus from an ill horse that ultimately was euthanized. Both the woman and child survived and showed no side effects from the treatment.

"This is an important research advance that illustrates how scientific discoveries emerge through a steady stepwise process, and how our investment in research on countermeasures for biodefense and emerging infectious diseases can help global preparedness efforts," said Anthony S. Fauci, M.D., director of the NIH's National Institute of Allergy and Infectious Diseases (NIAID).

Hendra virus emerged in 1994 in Australia and primarily affects horses, which can spread the disease to humans. No person-to-person transmission of Hendra has been reported. Nipah virus emerged in 1998 in Malaysia, and also has been found in Bangladesh and India. Nipah appears to infect humans more easily than Hendra and can be transmitted from person to person.

The NIAID-supported study, which appears online in Science Translational Medicine, involved infecting 14 African green monkeys with a lethal dose of Hendra virus. Twelve of the monkeys then received two treatments with m102.4, one either at 10, 24, or 72 hours after being infected, and another 48 hours later. All 12 monkeys treated with the antibody survived. The two untreated control monkeys died eight days after being infected.

The findings are the result of a series of studies carried out by different research laboratories. A group from NIH's National Cancer Institute and the Uniformed Services University of the Health Sciences (USUHS) discovered m102.4 in 2006 and developed the antibody for use in laboratory research. USUHS and Australian collaborators then developed an animal study model of m102.4 in ferrets infected with Nipah virus; the University of Texas Medical Branch and USUHS developed a monkey study model of Hendra and Nipah infection; and together with investigators from Boston University and NIAID's Rocky Mountain Laboratories (RML) designed and carried out the antibody trial in biosafety level-4 (BSL-4) laboratory space at RML. Because the Hendra and Nipah viruses are so deadly and there is no licensed vaccine or treatment for either of them, both viruses must be studied in maximum-containment BSL-4 laboratories.

The World Health Organization reports 475 human cases of Nipah through 2008, with 251 deaths. Through the same period, there have been seven human Hendra cases with four fatalities. There also have been many horse fatalities. In their study, the scientists cite a handful of other outbreaks of Hendra virus in horses since 2008. Since June 2011, there have been 18 outbreaks in Australia, primarily in Queensland and New South Wales, with the latest reported Oct. 10.

Both viruses are spread by fruit bats, commonly known as flying foxes, which are reservoirs for these viruses. The fruit bats, which are resistant to the diseases, are found primarily in Australia but have been found as far west as Africa, north to India and Pakistan, and east to the Philippines.

Additional studies on m102.4 as a possible treatment and as a preventive vaccine for Nipah and Hendra virus infections are being planned.

###

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Reference: K Bossart et al. A neutralizing human monoclonal antibody protects African Green monkeys from Hendra virus challenge. Science Translational Medicine. DOI: 10.1126/scitranslmed.3002901 (2011).

--------------------------------------------------------------------------------

Ken Pekoc | EurekAlert!
Further information:
http://www.nih.gov

More articles from Life Sciences:

nachricht Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY

nachricht NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>